11.45 0.00 (0.00%)
After hours: 4:44PM EST
|Bid||11.34 x 800|
|Ask||17.00 x 800|
|Day's Range||11.25 - 12.25|
|52 Week Range||11.25 - 27.23|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 14, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||26.05|
Calyxt, Inc. , a consumer-centric, food- and agriculture-focused company, today announced the company will report financial results for the third quarter of 2018 on Tuesday, November 13, after the close of regular stock market trading hours.
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused Company, announced today that Aaron Snyder has joined the Calyxt team as a supply chain manager, effective October 15, 2018. Mr. Snyder will be responsible for procuring all materials that are needed for production, as well as overseeing shipping operations, implementing and managing new planning processes. “Aaron’s impressive record in managing logistics operations and supply chain strategy makes him the perfect choice to manage our operations here at Calyxt,” said Jim Blome, CEO of Calyxt.
Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company has completed the inaugural harvest of its high-fiber wheat product, the world’s first gene-edited, consumer-focused wheat product. The high-fiber wheat product is already the seventh Calyxt product that has been deemed non-regulated by the U.S. Department of Agriculture (USDA), including powdery mildew-resistant wheat, high-oleic soybeans, high-oleic / low-linoleic soybeans, improved quality alfalfa, cold storable potatoes and reduced browning potatoes. “The completion of these field trials for our high-fiber wheat is an important milestone as we continue to advance toward the finish line in commercializing our first-ever gene-edited wheat product for consumers,” said Jim Blome, CEO of Calyxt.
NEW YORK, Oct. 09, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused company, announced today that the Company has inked an agreement with KemX Global, a leading provider of innovative organic processing of oils, to refine Calyxt’s high-oleic soybean oil – an advancement that will allow Calyxt to produce food-grade high-oleic soybean oil as the Company’s first product that is expected to hit the market in late 2018/ early 2019. “This agreement is another important step in scaling up Calyxt’s supply chain, leading up to the commercialization of our high-oleic soybean oil,” said Manoj Sahoo, Calyxt’s Chief Commercial Officer. “KemX’s Boone Plant, which has a strong reputation and Level 2 certification from the Safe Quality Food Institute, permits Calyxt to work with multiple crush plants in the Midwest region.
Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused Company, announced today an agreement with American Natural Processors (ANP), a leading provider of innovative non-GMO and organic processing of oils, flours and meals, to crush Calyxt’s high-oleic soybean variety, and produce the Company’s high oleic soybean oil, its first product expected to hit the market in late 2018 / early 2019. “With this collaboration, Calyxt has taken an important step toward the commercialization of our high-oleic soybean oil by contracting with a processor with a strong track record of food quality and safety, and that is committed to the non-gmo and organic industries,” said Manoj Sahoo, Calyxt Chief Commercial Officer.
Calyxt, Inc. (CLXT) and Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today the appointment of James A. Blome, former President and CEO of Bayer CropScience LP (North America), as Chief Executive Officer of Calyxt, effective October 1, 2018. Jim Blome will work closely with Calyxt’s Board of Directors to foster the development of the Company’s consumer-focused products, including the upcoming commercial launch of Calyxt’s first product, high-oleic soybean oil. Jim Blome is a high-impact, global leader with over 25 years of leadership experience in the agriculture industry, building teams and strategies with consumer-focused cultures to better meet consumer needs and maximize market share growth.
Calyxt, Inc. (CLXT) and Cellectis S.A. (NASDAQ:CLLS – EURONEXT GROWTH: ALCLS) announced today the appointment of James A. Blome, former President and CEO of Bayer CropScience LP (North America), as Chief Executive Officer of Calyxt, effective October 1, 2018. Jim Blome will work closely with Calyxt’s Board of Directors to foster the development of the Company’s consumer-focused products, including the upcoming commercial launch of Calyxt’s first product, high-oleic soybean oil. Jim Blome is a high-impact, global leader with over 25 years of leadership experience in the agriculture industry, building teams and strategies with consumer-focused cultures to better meet consumer needs and maximize market share growth.
Calyxt, Inc. (CLXT) announced today that Christopher J. Neugent, Executive Vice President of Strategy of Post Holdings, Inc. (POST), joined its board of directors. Mr. Neugent has nearly three decades of experience in the consumer packaged goods and food industries, including as President and CEO of Post Consumer Brands and as Chairman and CEO of MOM Brands, which was purchased by Post Holdings in 2015. “Mr. Neugent’s industry expertise and executive leadership will be invaluable to Calyxt during a pivotal time in our growth as we are heading to our first commercial launch of a product to market, our high oleic soybean oil” said Dr. André Choulika, Chairman of Calyxt’s Board of Directors.
Calyxt, Inc. (CLXT) and Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today its Board of Directors has appointed Yves Ribeill, Ph.D., as Interim Chief Executive Officer, effective immediately. Dr. Ribeill replaces Federico Tripodi, who is leaving the Company to pursue other opportunities. Currently a member of Calyxt’s Board of Directors, Dr. Ribeill will work closely with the executive management team to promote the development of the Company’s products to benefit consumers, including the commercial launch of Calyxt’s high-oleic soybean oil.
Calyxt Inc, an eight-year-old firm co-founded by a genetics professor, altered the genes of a soybean plant to produce healthier oil using the cutting-edge editing technique rather than conventional genetic modification. Seventy-eight farmers planted those soybeans this spring across 17,000 acres in South Dakota and Minnesota, a crop expected to be the first gene-edited crop to sell commercially, beating out Fortune 500 companies. Seed development giants such as Monsanto, Syngenta AG and DowDuPont Inc have dominated genetically modified crop technology that emerged in the 1990s.
Calyxt (CLXT) delivered earnings and revenue surprises of 7.41% and 96.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The New Brighton, Minnesota-based company said it had a loss of 25 cents per share. The genetically modified food company posted revenue of $196,000 in the period. Calyxt shares have decreased 20 percent ...
As of June 30th, successfully contracted over 17,000 high-oleic / no trans-fat soybean acres with 78 growers.
Gene editing in agriculture takes centre stage next Wednesday when Europe's highest court rules in a case that could determine the fate of the technology that is already making waves in the field of medicine. The European Union has long restricted the use of genetically modified organisms (GMOs) widely adopted around the world, but there is legal uncertainty as to whether modern gene editing of crops should fall under the same strict GMO rules. The European Court of Justice (ECJ) will rule whether the use of genetic mutation, or mutagenesis, which is now exempt from GMO rules, should differentiate between techniques that have been used for decades and the new gene-editing technology.
Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused company, and S&W Seed Company (SANW), a global leader in the alfalfa seed industry, today announced the successful transfer of their proprietary alfalfa seed and plants from the research and development facility at Calyxt to S&W for field evaluation and testing. In 2015, Calyxt and S&W Seed Company embarked on a collaboration to research, develop, produce and commercialize alfalfa seed products involving Calyxt’s proprietary gene editing technology, TALEN®, and S&W’s industry-leading alfalfa seed genetics. The collaboration between Calyxt and S&W is focused on providing enhanced traits in alfalfa that can drive improved productivity, while decreasing input costs to meet the growing global demand for improved quality alfalfa seeds.
Cellectis S.A. and Calyxt, Inc. today announced the closing of Calyxt’s follow-on public offering of 4,057,500 shares of Calyxt’s common stock at a public offering price of $15.00 per share.